Movement Alert｜Spyre Therapeutics Rises 8.19% in After-Hours Trading, Trading at $105.0

Market Focus06-24

On June 23, Spyre Therapeutics rose 8.19% in after-hours trading, trading at $105.0/share, with turnover of $4.1119 million.

Within the Biotechnology sector where Spyre Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, AbbVie down 0.12%, Apogee Therapeutics down 0.14%, Gilead Sciences up 0.32%, Regeneron Pharmaceuticals down 0.33%, Amgen down 0.58%.

Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4β7), SPY002 (anti-TL1A), and SPY003 (anti-IL-23) monoclonal antibodies, as well as combination therapies SPY120, SPY130, and SPY230.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1120579856?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 04:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120579856","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Spyre Therapeutics Rises 8.19% in After-Hours Trading, Trading at $105.0","media":"Market Focus","content":"<p><p>On June 23, Spyre Therapeutics rose 8.19% in after-hours trading, trading at $105.0/share, with turnover of $4.1119 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, AbbVie down 0.12%, Apogee Therapeutics down 0.14%, Gilead Sciences up 0.32%, Regeneron Pharmaceuticals down 0.33%, Amgen down 0.58%.</p><p>Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4β7), SPY002 (anti-TL1A), and SPY003 (anti-IL-23) monoclonal antibodies, as well as combination therapies SPY120, SPY130, and SPY230.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Spyre Therapeutics Rises 8.19% in After-Hours Trading, Trading at $105.0</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Spyre Therapeutics Rises 8.19% in After-Hours Trading, Trading at $105.0\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 04:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 23, Spyre Therapeutics rose 8.19% in after-hours trading, trading at $105.0/share, with turnover of $4.1119 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, AbbVie down 0.12%, Apogee Therapeutics down 0.14%, Gilead Sciences up 0.32%, Regeneron Pharmaceuticals down 0.33%, Amgen down 0.58%.</p><p>Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4β7), SPY002 (anti-TL1A), and SPY003 (anti-IL-23) monoclonal antibodies, as well as combination therapies SPY120, SPY130, and SPY230.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1120579856","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120579856","pubTimestamp":1782247352,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 23, Spyre Therapeutics rose 8.19% in after-hours trading, trading at $105.0/share, with turnover of $4.1119 million.Within the Biotechnology sector where Spyre Therapeutics belongs,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC"},"translate_title":"走势提示|Spyre Therapeutics盘后涨8.19%，报105.0美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":1},"content_text":"On June 23, Spyre Therapeutics rose 8.19% in after-hours trading, trading at $105.0/share, with turnover of $4.1119 million.Within the Biotechnology sector where Spyre Therapeutics belongs, individual stocks showed mixed performance. Among individual stocks, AbbVie down 0.12%, Apogee Therapeutics down 0.14%, Gilead Sciences up 0.32%, Regeneron Pharmaceuticals down 0.33%, Amgen down 0.58%.Spyre Therapeutics is a preclinical stage biotechnology company focused on developing therapeutics for patients with inflammatory bowel disease. Its pipeline includes SPY001 (anti-a4β7), SPY002 (anti-TL1A), and SPY003 (anti-IL-23) monoclonal antibodies, as well as combination therapies SPY120, SPY130, and SPY230.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1120579856","isCrawlerRequest":true}